Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
Gerald S. Falchook(The University of Texas MD Anderson Cancer Center), Matthew G. Fury(Regeneron (United States)), Carlo Bifulco(Providence Health & Services), Rom S. Leidner(Providence Portland Medical Center), Israel Lowy(Bristol-Myers Squibb (Germany)), Brian Piening(Providence College), Elizabeth Stankevich(Regeneron (United States))
Cited by 151
Related Papers
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803